查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466559

顱內動脈瘤市場：按類型、適應症和最終用戶分類 - 全球預測 2024-2030

Intracranial Aneurysm Market by Type (Artery Occlusion & Bypass, Endovascular Coiling, Flow Diverters), Indication (Ruptured Aneurysm, Unruptured Aneurysm), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年顱內動脈瘤市場規模為13.2億美元，預計2024年將達16億美元，2030年將達53.8億美元，複合年成長率為22.16%。

顱內動脈瘤市場是一個醫療保健產業領域，專注於顱內動脈壁膨出或氣球的診斷、治療和管理。該市場包括各種產品和服務，包括診斷設備、手術器械、藥物以及各種治療選擇，包括手術和非手術干預措施。顱內動脈瘤市場的成長受到全球人口老化、高血壓和吸菸盛行率增加、醫學影像技術進步以及公眾對該疾病認知不斷提高等因素的影響。此外，醫療基礎設施的改善、醫療支出的增加以及微創手術需求的增加也促進了市場的擴張。影響顱內動脈瘤市場成長的限制包括治療成本高、低度開發和開拓地區醫療設施的使用機會有限以及與侵入性外科手術相關的風險。除此之外，產品核可還存在嚴格的法律規範，需要能夠進行專門介入的熟練專業人員。然而，隨著新技術的出現，市場持續成長，包括開拓更有效、侵入性更小的治療技術、應用人工智慧增強成像和診斷，以及將新型生物材料引入血管內治療中使用的支架和線圈。我們正在見證一個巨大的潛在機會。此外，基因研究的進步可能會帶來更早的檢測和個人化的治療策略。

主要市場統計
基準年[2023] 13.2億美元
預測年份 [2024] 16億美元
預測年份 [2030] 53.8億美元
複合年成長率（%） 22.16%

微創技術的需求，例如小囊狀動脈瘤的血管內卷取

動脈閉塞和搭橋手術是當微創治療方法被認為困難或危險時所使用的一種外科手術。這些手術會關閉受影響的動脈，並使用血管移植物轉移血流以維持腦循環。此手術通常用於不適合血管內治療或先前治療失敗的複雜動脈瘤。血管內卷取是一種微創手術，將導管插入動脈並引導至動脈瘤部位。然後透過導管將軟金屬線圈放入動脈瘤中，以促進血液凝固並防止血液流入動脈瘤，從而降低破裂的風險。通常選擇血管內卷取來治療許多顱內動脈瘤，因為與開放性手術相比，它的侵入性較小且需要的恢復時間較短。分流器是一種血管內裝置，設計用於治療主動脈瘤和巨大動脈瘤，以及治療不適合彈簧圈的寬基底動脈瘤。這些類似支架的裝置被放置在動脈瘤頸部，以將血流從動脈瘤囊中轉移出來。隨著時間的推移，這會導致動脈瘤內血栓症，從而導致受影響血管段的重組。分流器可有效閉塞動脈瘤，同時維持載瘤動脈的血流。手術夾閉是顱內動脈瘤的傳統且確定的治療方法，透過開顱手術暴露動脈瘤。然後，神經外科醫生在動脈瘤底部放置一個小金屬夾，有效地將其與動脈血流隔離。這可以防止動脈瘤生長或破裂。儘管該手術是侵入性的並且需要很長的恢復時間，但它是一種持久的解決方案，具有很高的長期成功率。

最終用戶：越來越多的診所尋求早期篩檢和診斷服務的患者數量

診所，特別是神經科和放射科的診所，提供顱內動脈瘤的診斷和治療服務。這些設施通常比醫院小，並且往往因其早期診斷、門診護理和便利性而受到患者的青睞。醫院是顱內動脈瘤治療最全面的最終用途區域，提供全方位的診斷、手術和術後照護。醫院通常配備先進的神經影像技術，例如高解析度 MRI 和 CT 掃描儀，這對於動脈瘤治療的準確診斷和術前規劃至關重要。在醫院，顯微手術夾閉等開放性手術以及彈簧圈和轉移等血管內手術均在設備齊全的手術室中進行，手術室配備了訓練有素的介入神經放射學放射科醫生和神經外科醫生。治療後，醫院會提供加護病房來監測患者，特別是在侵入性手術後或出現動脈瘤破裂等併發症時。

區域洞察

在美洲，顱內動脈瘤的盛行率受到遺傳、環境和生活型態因素的綜合影響。目前正在對醫療基礎設施和神經系統疾病（包括顱內動脈瘤）的研究進行大量投資。美國和加拿大擁有先進的醫療保健系統，診斷和治療率很高，包括外科手術和微創手術。在歐洲、中東和非洲地區，顱內動脈瘤的調查和治療在歐洲非常活躍，許多國家採用了最新的血管內治療方法，例如彈簧圈栓塞和血流改道。在中東，隨著神經介入設施的可用性增加，醫療保健基礎設施也不斷發展。然而，由於歐洲、中東和非洲地區社會經濟和醫療保健系統的多樣性，盛行率和管理實踐各不相同。儘管非洲面臨衛生資源有限的挑戰，但主要都市區仍持續取得進展。在亞太地區，顱內動脈瘤的情況多種多樣。日本和韓國等國家技術採用率較高，且注重醫療創新。中國和印度等國家正在迅速發展醫療基礎設施，改善神經血管治療的機會。

FPNV定位矩陣

FPNV定位矩陣對於評估顱內動脈瘤市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對顱內動脈瘤市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.顱內動脈瘤市場規模及預測是多少？

2.顱內動脈瘤市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3.顱內動脈瘤市場的技術趨勢和法規結構是什麼？

4.顱內動脈瘤市場主要廠商的市場佔有率是多少？

5.進入顱內動脈瘤市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 生活型態改變導致腦血管疾病發生率增加
      • 顱內動脈瘤微創治療趨勢
      • 改善顱內動脈瘤的診斷
    • 抑制因素
      • 與治療相關的副作用和治療費用上漲
    • 機會
      • 活性化研發活動並推出創新技術產品
      • 血管內彈簧圈栓塞的潛力不斷增加
    • 任務
      • 有關手術時機和麻醉誘導的問題
  • 市場區隔分析
    • 類型：對微創技術的需求，例如針對較小囊狀動脈瘤的血管內彈簧圈栓塞術
    • 最終用戶：尋求早期篩檢和診斷服務的診所之間的患者流量增加
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章顱內動脈瘤市場：依類型

  • 動脈閉塞和搭橋
  • 血管內彈簧圈栓塞
  • 分流器
  • 手術夾閉

第7章顱內動脈瘤市場（按適應症）

  • 動脈瘤破裂
  • 未破裂動脈瘤

第8章顱內動脈瘤市場：依最終用戶分類

  • 診所
  • 醫院

第9章 北美及南美顱內動脈瘤市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區顱內動脈瘤市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的顱內動脈瘤市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Evasc 宣布臨床里程碑並計劃與德國子公司擴大歐洲業務
    • OU研究人員設計設備以改善腦動脈瘤的治療

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-A339DAEF9EC7

[186 Pages Report] The Intracranial Aneurysm Market size was estimated at USD 1.32 billion in 2023 and expected to reach USD 1.60 billion in 2024, at a CAGR 22.16% to reach USD 5.38 billion by 2030.

The intracranial aneurysm market is the healthcare industry sector focused on diagnosing, treating, and managing intracranial aneurysms, bulges, or ballooning in the walls of arteries within the cranium. The market includes various products and services such as diagnostic equipment, surgical tools, medications, and a wide range of treatment options, including surgical and non-surgical interventions. Growth in the intracranial aneurysm market is influenced by factors such as the aging global population, the increasing prevalence of hypertension and smoking, advancements in medical imaging technologies, and the rise in public awareness about the condition. Additionally, improvements in healthcare infrastructure, increased healthcare spending, and the growing demand for minimally invasive surgeries contribute to market expansion. Limitations affecting the intracranial aneurysm market growth include high treatment costs, limited access to healthcare facilities in underdeveloped and developing regions, and the risks associated with invasive surgical procedures. Along with these, stringent regulatory frameworks governing product approval and the need for skilled professionals capable of performing specialized interventions. However, the market witnessed new potential opportunities, including developing more effective and less invasive treatment techniques, applying artificial intelligence for enhanced imaging and diagnostics, and introducing novel biomaterials for stents and coils used in endovascular treatments. Furthermore, advancements in genetic research could lead to early detection and personalized treatment strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 1.32 billion
Estimated Year [2024] USD 1.60 billion
Forecast Year [2030] USD 5.38 billion
CAGR (%) 22.16%

Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms

Artery occlusion and bypass procedures are surgical interventions utilized when an intracranial aneurysm is considered too difficult or dangerous to treat with less invasive methods. These procedures involve closing off the affected artery and rerouting the blood flow using a vessel graft to preserve cerebral circulation. This technique is typically reserved for complex aneurysms that are not amenable to endovascular techniques or where previous treatments have failed. Endovascular coiling is a minimally invasive procedure that implicates inserting a catheter into an artery and navigating it to the aneurysm site. Soft metal coils are then deployed through the catheter into the aneurysm, promoting blood clotting and preventing blood flow into the aneurysm, thus reducing the risk of rupture. Endovascular coiling is often the preferred choice for treating many intracranial aneurysms due to its less invasive nature and reduced recovery time compared to open surgery. Flow diverters are endovascular devices designed to treat large and giant aneurysms and those with a wide base that is not suitable for coiling. These stent-like devices are placed across the neck of the aneurysm to redirect blood flow away from the aneurysm sac. Over time, this leads to thrombosis within the aneurysm and reconstruction of the affected vessel segment. Flow diverters are effective in occluding aneurysms while preserving blood flow in the parent artery. Surgical clipping is a traditional and definitive treatment for intracranial aneurysms that involves a craniotomy to expose the aneurysm. A neurosurgeon then places a small metal clip at the base of the aneurysm, effectively isolating it from the arterial blood flow. This prevents the aneurysm from growing or rupturing. While the procedure is invasive and requires a longer recovery period, it is a durable solution with a high long-term success rate.

End User: Rising patient flow across clinics for early screening and diagnostic services

Clinics, particularly those specializing in neurology and radiology, provide services for diagnosing and treating intracranial aneurysms. These facilities are usually smaller than hospitals and are often preferred by patients for early diagnosis, outpatient care, and convenience. Hospitals represent the most comprehensive end-use segment for intracranial aneurysm management, offering a full spectrum of diagnostic, surgical, and postoperative care. They are typically equipped with advanced neuroimaging technologies, such as high-resolution MRI and CT scanners, essential for the precise diagnosis and preoperative planning of aneurysm treatment. Hospitals facilitate open surgical procedures, such as microsurgical clipping, and endovascular therapies, such as coiling or flow diversion, conducted in well-equipped operating theaters with trained neuro-interventional radiologists and neurosurgeons. Post-treatment, hospitals provide intensive care units for monitoring patients, particularly after invasive surgeries or in the event of complications such as aneurysm rupture.

Regional Insights

In the Americas, the prevalence of intracranial aneurysms is influenced by a combination of genetic, environmental, and lifestyle factors. There is a substantial investment in healthcare infrastructure and research into neurological disorders, including intracranial aneurysms. The U.S. and Canada have advanced healthcare systems with high diagnosis and treatment rates, including surgical interventions and minimally invasive procedures. In the EMEA region, Europe has significant research and management of intracranial aneurysms, with many countries adopting modern endovascular treatments such as coiling and flow diversion. The Middle East has seen growth in healthcare infrastructure with the increasing availability of neurointerventional facilities. However, there are variations in prevalence and management approaches due to diverse socioeconomic and healthcare systems across the EMEA. Africa faces challenges due to limited healthcare resources, but there is ongoing progress in major urban centers. The Asia-Pacific region presents a varied landscape for intracranial aneurysms. Countries including Japan and South Korea have high technological adoption rates and a strong focus on innovation in medical treatments. Countries such as China and India are rapidly developing their healthcare infrastructure, improving access to neurovascular care.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intracranial Aneurysm Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intracranial Aneurysm Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intracranial Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abbvie Inc., Acandis GmbH, Adeor Medical AG, B. Braun Melsungen AG, Balt Extrusion S.A., Bayer AG, Bristol-Myers Squibb Company, Cardiatis, S.A., Evasc Medical Systems Corp, F. Hoffmann-La Roche AG, Integra Lifesciences Holdings Corporation, Johnson & Johnson Services, Inc., Kaneka Corporation, Medtronic PLC, Merck & Co., Inc., Microport Scientific Corporation, Mizuho Medical Co,Ltd., Oxford Endovascular Ltd., Penumbra, Inc., Pfizer Inc., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Artery Occlusion & Bypass
    • Endovascular Coiling
    • Flow Diverters
    • Surgical Clipping
  • Indication
    • Ruptured Aneurysm
    • Unruptured Aneurysm
  • End User
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intracranial Aneurysm Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intracranial Aneurysm Market?

3. What are the technology trends and regulatory frameworks in the Intracranial Aneurysm Market?

4. What is the market share of the leading vendors in the Intracranial Aneurysm Market?

5. Which modes and strategic moves are suitable for entering the Intracranial Aneurysm Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
      • 5.1.1.2. Inclination for Minimally Invasive Intracranial Aneurysm Procedures
      • 5.1.1.3. Improved Diagnosis for Intracranial Aneurysm
    • 5.1.2. Restraints
      • 5.1.2.1. Side Effects Associated with Therapies and High Cost of Treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in Research and Development Activities and Introduction of Innovative Technology Products
      • 5.1.3.2. Rising Potential for Endovascular Coiling
    • 5.1.4. Challenges
      • 5.1.4.1. Issues Related to Timing of Surgery and Anesthetic Induction
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms
    • 5.2.2. End User: Rising patient flow across clinics for early screening and diagnostic services
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Intracranial Aneurysm Market, by Type

  • 6.1. Introduction
  • 6.2. Artery Occlusion & Bypass
  • 6.3. Endovascular Coiling
  • 6.4. Flow Diverters
  • 6.5. Surgical Clipping

7. Intracranial Aneurysm Market, by Indication

  • 7.1. Introduction
  • 7.2. Ruptured Aneurysm
  • 7.3. Unruptured Aneurysm

8. Intracranial Aneurysm Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Intracranial Aneurysm Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intracranial Aneurysm Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Aneurysm Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Evasc announces clinical milestones and plans to expand European presence with German subsidiary
    • 12.3.2. OU Researchers Designing Device to Improve Brain Aneurysm Treatment

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. INTRACRANIAL ANEURYSM MARKET RESEARCH PROCESS
  • FIGURE 2. INTRACRANIAL ANEURYSM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTRACRANIAL ANEURYSM MARKET DYNAMICS
  • FIGURE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRACRANIAL ANEURYSM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ARTERY OCCLUSION & BYPASS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ARTERY OCCLUSION & BYPASS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY RUPTURED ANEURYSM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY RUPTURED ANEURYSM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY UNRUPTURED ANEURYSM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY UNRUPTURED ANEURYSM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 283. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023